Hughes Report: First Anniversary

Supported interim payments to victims and highlighted a case involving sodium valproate affecting his constituent's daughter, raising awareness for compensation needs.

Addressed sodium valproate's risks during pregnancy, mentioning his constituent Karen Buck whose children were affected. He asked for a response to the petition with over 1,000 signatures and highlighted the need for primary legislation.

Paula and Gillian are constituents impacted by pelvic mesh, reflecting the broader issue of 10,000 women harmed. Daniel Francis supports research into anti-seizure medications during pregnancy and calls for dedicated funding.

Emphasises the importance of support for victims like Paula and Gillian, highlighting the need for swift action on safety concerns and continued review of valproate prescriptions' impacts.

Echoes concerns raised by the lead MP and asks for updates on implementing recommendations from the Hughes report. Emphasizes the need for progress and clarity regarding financial redress, meetings with Dr Henrietta Hughes, communication with affected individuals, and the status of workstreams related to teratogenic medications.

Colleen and her son Byron are constituents affected by valproate prescriptions during pregnancy. Byron has autism, learning disabilities, and speech issues due to the drug's harmful effects. James Wild demands a commitment from the Government for compensation payments and an apology.

At least 10,000 women in England have been harmed by vaginal mesh implants, and the true number could be closer to 40,000. The report recommends establishing an independent redress agency for these victims.

5,255 women in Northern Ireland underwent vaginal tape procedures between 2007 and 2015, with some experiencing chronic pain and infections post-surgery.

Cited recent precedents for interim payments under the infected blood compensation scheme, suggesting a mechanism that maximizes entitlements without loss to the public purse.

A constituent's daughter was born with autism as a direct result of sodium valproate prescribed to control her epilepsy, leading to guilt and self-blame for the mother.

Highlighted the experiences of a constituent who suffered severe health issues due to pelvic mesh implants, including ongoing treatment for cancer. The constituent's case is one of at least 10,000 cases where people are seeking redress.

Focused on mesh implants' effects and supported his constituent Bev's case. He expressed disappointment that sodium valproate issues have not been fully resolved despite previous efforts.

Thanked everyone for their valuable contributions to the debate. Emphasised the need for action based on existing information from Baroness Cumberlege and the Patient Safety Commissioner to prevent future scandals and provide compensation.

Discussed the importance of research and reaching out to global experts like Dr Dionysios Veronikis for effective mesh removal methods. Raised concerns about legal cases, waiting lists, and financial support. Suggested making an interim payment to address frustrations about timescales.

Asked about ensuring that medical devices used were properly licensed, highlighting the importance of preventing misuse of approved products without further testing.

Shared a constituent's experience of enduring years of pain due to mesh implants and the need for urgent investment in urogynaecology services. The constituent had to pay for private healthcare to remediate the issue, highlighting the urgency.

Argues that a proper Government-backed compensation scheme will ultimately save the NHS money by reducing legal costs and payouts. Discussed her experience handling clinical negligence claims on behalf of women affected by mesh implants, highlighting the need for a quick-working redress system that provides both financial and non-financial compensation.